Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2005 | 10-2004 | 10-2003 | 10-2002 | 10-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 507 | 1,003 | 1,024 | 855 | 1,317 |
| Marketable Securities | 401 | N/A | N/A | N/A | N/A |
| Receivables | 32 | 148 | 169 | 401 | 536 |
| Inventories | 385 | 999 | 1,045 | 1,296 | 1,589 |
| TOTAL | $1,404 | $2,273 | $2,285 | $2,654 | $3,580 |
| Non-Current Assets | |||||
| PPE Net | 27 | 38 | 40 | 72 | 120 |
| Other Non-Current Assets | 35 | 6 | 6 | 6 | 2,863 |
| TOTAL | $62 | $44 | $46 | $77 | $2,983 |
| Total Assets | $1,466 | $2,316 | $2,331 | $2,732 | $6,562 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 271 | 403 | 317 | 379 | 816 |
| Accrued Expenses | 77 | 41 | 25 | 35 | 38 |
| TOTAL | $348 | $443 | $342 | $414 | $2,396 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,542 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $348 | $443 | $342 | $414 | $2,396 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,750 | 3,472 | 3,224 | 2,897 | 2,689 |
| Common Shares | 920 | 855 | 802 | 703 | 665 |
| Retained earnings | -72,908 | -68,456 | -65,096 | -61,981 | -58,696 |
| TOTAL | $1,118 | $1,873 | $1,988 | $2,318 | $4,167 |
| Total Liabilities And Equity | $1,466 | $2,316 | $2,331 | $2,732 | $6,562 |